Emtriva Capsules is a brand of medicine containing the active ingredient emtricitabine.
Find out more about active ingredients.
Consumer medicine information (CMI) leaflet
Developed by the pharmaceutical company responsible for this medicine in Australia, according to TGA regulations.
EMTRIVA® 200 mg Capsules
Consumer Medicine Information
WHAT IS IN THIS LEAFLET
Read all of this leaflet carefully before you start taking this medicine.
This leaflet answers some of the common questions about EMTRIVA capsules. It does not contain all the available information.
It does not take the place of talking to your doctor or pharmacist about your medical condition or treatment. If you have further questions, please ask your doctor or your pharmacist.
Keep this leaflet with your EMTRIVA capsules. You may need to read it again.
This medicine has been prescribed for you personally and you should not pass it on to others. It may harm them, even if their symptoms are the same as yours.
WHAT EMTRIVA CAPSULES ARE USED FOR
- EMTRIVA belongs to a group of antiviral medicines, called nucleoside reverse transcriptase inhibitors (NRTIs).
- EMTRIVA is used to treat Human Immunodeficiency Virus (HIV) infection in adults and paediatric patients 12 years of age or older who weigh more than 33 kg. This medicine must be taken in combination with other anti-HIV medicines.
- This medicine is not a cure for HIV infection. While taking EMTRIVA you may still develop infections or other illnesses associated with HIV infection.
BEFORE YOU TAKE EMTRIVA CAPSULES
When you must not take them
- If you are hypersensitive (allergic) to emtricitabine or any of the other ingredients of EMTRIVA. Read the side effects section to find out symptoms of allergy. The ingredients of EMTRIVA are listed in the product description section of this leaflet.
- Do not take EMTRIVA, if you are already taking TRUVADA (tenofovir disoproxil fumarate/ emtricitabine combination tablet), ATRIPLA (tenofovir disoproxil fumarate/ emtricitabine/efavirenz combination tablet), EVIPLERA (tenofovir disoproxil fumarate/ emtricitabine/ rilpivirine combination tablet), STRIBILD (tenofovir disoproxil fumarate/emtricitabine/elvitegravir/cobicistat), Combivir, 3TC, Zeffix, Kivexa, Trizivir or any other medications containing lamivudine.
- Do not take EMTRIVA if you are over the age of 65 before discussing this with your doctor.
- Do not use EMTRIVA to treat any other condition unless your doctor says that you should do so.
- Do not take EMTRIVA after the expiry or “use by” date (EXP) printed on the back of the pack. If you take it after the expiry date has passed, it may not work as well.
- Do not take EMTRIVA if the packaging is torn or shows signs of tampering.
If you are not sure whether you should be taking EMTRIVA, talk to your doctor.
Before you start to take EMTRIVA
You must tell your doctor if:
- You are allergic to foods, dyes, preservatives or any other medicines.
- You are pregnant, trying to become pregnant or breast feeding.
The safe use of EMTRIVA in human pregnancy has not been demonstrated. For this reason, it is important that women of child-bearing age receiving treatment with EMTRIVA use an effective method of contraception to avoid becoming pregnant. The active substance in this medicine (emtricitabine) has been found in breast milk at low concentrations. Consequently, it is recommended that nursing mothers do not breast feed during treatment with EMTRIVA. In general, women infected with HIV should not breast feed their infants in order to avoid transmission of HIV to their newborn infant.
- You have or have ever had liver problems including hepatitis B infection.
- You have or have ever had kidney problems.
This medicine is only available from a pharmacist after it has been prescribed by a doctor who specialises in the treatment of HIV infection. If you wish to continue receiving treatment with EMTRIVA it is important you remain under the care of a hospital or doctor who specialises in the treatment of HIV infection.
EMTRIVA does not reduce the risk of passing HIV to others through sexual contact or blood contamination. Therefore, it is important to continue to take appropriate precautions to prevent passing HIV to others.
If you have a long standing viral infection of your liver (hepatitis B) it may flare up when you stop taking EMTRIVA. This can cause serious illness particularly if your liver is already not working very well. If you have both HIV and hepatitis B, when you start taking your EMTRIVA capsules and even after you stop, your doctor is likely to arrange tests from time to time to check how well your liver is working.
Taking other medicines
Your doctor will generally prescribe EMTRIVA in combination with a number of other anti-HIV medicines.
Tell your doctor if:
- You are taking any other medicines, including medicines you buy without a prescription from a pharmacy, supermarket or health food shop.
- Some medicines may affect the way others work. Your doctor or pharmacist will be able to tell you what to do when taking EMTRIVA with other medicines.
HOW TO TAKE EMTRIVA
Always take the dose recommended by your doctor to ensure that your medicine is fully effective and to reduce the development of drug resistance.
How much to take
Take one EMTRIVA 200 mg capsule once daily with or without food or as advised by your doctor.
- If you are not sure how much EMTRIVA you should take, check with your doctor or pharmacist. Do not change the amount of EMTRIVA you take unless told to do so by your doctor.
- Your doctor will tell you how much EMTRIVA to take and how often to take them. You will also find this information on the label of your medicine container.
EMTRIVA is absorbed rapidly. Do not take another EMTRIVA 200 mg capsule if vomiting has occurred unless it occurs within 1 hour after taking EMTRIVA.
How long to take EMTRIVA
Because your medicine helps to control your condition, but does not cure it, you will need to take EMTRIVA every day. Do not stop taking EMTRIVA without first talking to your doctor.
If you forget to take EMTRIVA
It is important to take the prescribed daily dose in order to get the maximum benefit of treatment.
If you forget to take your daily dose of EMTRIVA take it as soon as you remember. Do not take a double dose to make up for a forgotten dose. Do not take more than one dose of EMTRIVA in a day.
If you take too much (Overdose)
Immediately telephone your doctor or Poisons Information Centre (telephone 13 11 26), or in New Zealand the Poisons Centre (telephone 0800 764 766) or go to the accident and emergency department at your nearest hospital if you think you or anyone else may have taken too many EMTRIVA capsules. Do this even if there are no signs of discomfort or poisoning. This may need urgent medical attention.
WHEN YOU ARE TAKING EMTRIVA CAPSULES
Things you must do
- Tell your doctor or pharmacist that you are taking EMTRIVA if you are about to be started on any other medicines.
- Tell your doctor if you become pregnant or are trying to become pregnant.
- Tell your doctor if for any reason you have not taken your medicine exactly as prescribed.
Things you must not do
- Do not stop taking EMTRIVA capsules or change the dose without first checking with your doctor.
- Do not give this medicine to anyone else even if their symptoms seem similar to yours.
- Do not use EMTRIVA to treat any other complaints unless you doctor says to.
Things to be careful of
Be careful driving or operating machinery until you know how the EMTRIVA capsules affect you.
POSSIBLE SIDE EFFECTS
Like all medicines, EMTRIVA can have side effects. Some may be serious and need medical attention.
Check with your doctor as soon as possible if you have any problems while taking EMTRIVA, even if you do not think the problems are connected with the medicine or are not listed in this leaflet.
Tell your doctor or pharmacist if you notice any of the following and they worry you:
- Muscle pain and weakness
- Skin rash
- Changes in skin colour on the palms of the hands or soles of the feet
- Difficulty sleeping
- Abnormal dreams
- Problems with digestion
Redistribution, accumulation or loss of body fat may occur in people receiving combination antiretroviral therapy. Contact your doctor if you notice changes in body fat.
Ask your doctor or pharmacist to answer any question you may have about these or other effects.
Some people are allergic to medicines. If you have any of the following symptoms soon after taking your medicine, DO NOT TAKE ANY MORE EMTRIVA and tell your doctor IMMEDIATELY or go to the accident and emergency department at your nearest hospital:
- Skin troubles such as lumpy skin rash or “hives”
- Swelling of the face, lips, mouth or throat which may cause difficulty in swallowing or breathing
- Wheezing, chest pain or tightness
These are very serious effects. If you have them, you may have a serious allergic reaction. You may need urgent medical attention or hospitalisation. All of these side effects are very rare.
Serious Liver Problems (hepatotoxicity)
If you have any of the following symptoms after starting taking your medication DO NOT TAKE ANY MORE EMTRIVA OR OTHER ANTI-HIV MEDICINES and tell your doctor IMMEDIATELY or go to the accident and emergency department at your nearest hospital.
- Your skin or the white part of your eyes turn yellow (jaundice)
- Your urine turns dark
- Your bowel movements (stools) turn light in colour
- Stomach pains
These side effects may be due to a condition called hepatotoxicity with liver enlargement and fat deposits in the liver (steatosis) which sometimes occurs in patients taking anti-HIV medicines.
If you have any of the following symptoms after taking your medication DO NOT TAKE ANY MORE EMTRIVA OR OTHER ANTI-HIV MEDICINES and tell your doctor IMMEDIATELY or go to the accident and emergency department at your nearest hospital.
- You feel very weak or tired.
- You have unusual (not normal) muscle pain.
- You have trouble breathing.
- You have stomach pain with nausea and vomiting.
- You feel cold, especially in your arms and legs.
- You feel dizzy or lightheaded.
- You have a fast or irregular heartbeat.
These side effects may be due to a condition called lactic acidosis (build up of an acid in the blood). Lactic acidosis can be a medical emergency and may need to be treated in the hospital.
If you have HIV infection and chronic hepatitis B infection you should not stop your EMTRIVA treatment without first discussing this with your doctor, as some patients have had blood tests or symptoms indicating a worsening of their hepatitis (“hepatic flare”) after stopping EMTRIVA. You may require blood tests for several months after stopping treatment.
Other side effects
This list of side effects is not complete. There have been other side effects in patients taking EMTRIVA. Tell your doctor if you notice anything else that is making you feel unwell, even if it is not on this list.
Some people may get other side effects while taking EMTRIVA. If you are concerned, talk to your doctor or pharmacist.
Ask your doctor or pharmacist if you don’t understand anything in this list.
Do not be alarmed by this list of possible side effects. Most of them are very rare and you may not experience any of them.
AFTER TAKING EMTRIVA
Keep EMTRIVA capsules where children cannot reach them. A locked cupboard at least one-and-a half metres above the ground is a good place to store them.
Keep EMTRIVA capsules in a cool, dry place where it stays below 30°C.
Do not store EMTRIVA or any other medicine in a bathroom or near a sink.
Do not leave them in the car or on a window sill - heat and dampness can destroy some medicines.
Keep your EMTRIVA capsules in the bottle with the cap tightly closed until you take them. If you take EMTRIVA capsules out of their pack they may not keep well.
If your doctor tells you to stop taking EMTRIVA, or the medicine has passed their expiry date, ask your pharmacist what to do with any capsules left over.
What EMTRIVA capsules look like
EMTRIVA 200 mg hard capsules have a white opaque body with a light blue opaque cap. Each capsule is printed with “200 mg” on the white cap and “GILEAD” and the Gilead shield logo on the white body in black ink. EMTRIVA capsules are supplied in bottles containing 30 capsules.
EMTRIVA Capsule Ingredients
Each EMTRIVA capsule contains 200 mg emtricitabine.
Other ingredients are:
- Cellulose, microcrystalline
- Magnesium stearate
- Purified water
- Capsule shell
- Printing ink
AUST R 96426, 96427
Gilead Sciences Pty Ltd
Level 6, 417 St Kilda Road
Melbourne, Victoria 3004
Gilead Sciences (NZ)
Level 8 Pricewaterhousecoopers Tower
188 Quay Street
Date of preparation: 5 September 2014
VIREAD, EMTRIVA, TRUVADA, EVIPLERA, STRIBILD and HEPSERA are registered trademarks of Gilead Sciences, Inc. ATRIPLA is a trademark of Bristol-Myers Squibb & Gilead Sciences, LLC. Other brands listed are trademarks of their respective owners and are not trademarks of Gilead Sciences, Inc, or Bristol-Myers Squibb & Gilead Sciences, LLC.
CMI provided by MIMS Australia, March 2015